Mergers and Acquisitions

As indicated under Key Objectives, risk management is a very important factor for a successful strategy. The number of projects and products and their generic and specific risks dictate the business strategy (financing needs, keep projects in house versus early out-sourcing, etc.). “Search” meaning in-licensing of projects and products (by product or M&A) offer one route to early broaden the portfolio of projects and products thereby increasing the overall statistical chance of success.

Bringing a pharmaceutical product from discovery research to the market can take anywhere from five to 15 years depending on type of project. M&A can be concluded within months and can include projects at any stage of development. It therefore offers one avenue to gain time in the development of a sizeable pharmaceutical company.

Chesyl assists its associated companies in selecting appropriate M&A strategies and supports the implementation.

Mergers & Acquisitions brief of Norwood Immunology LTD

Link to Merger and Acquisitions Briefing Paper (HTML)

Link to Merger and Acquisitions Briefing Paper (PDF Download)